United States
-
Corcept Therapeutics Announces Waiver of Condition to its Tender Offer for Common Shares
MENLO PARK, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) — Corcept Therapeutics Incorporated (NASDAQ: CORT) (“Corcept”), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by…
Read More »